Cited by 309Immunotherapy and Immune ResponsesRNA Interference and Gene DeliveryT-cell and B-cell Immunology

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity

Kreiter, Sebastian, Selmi, Abderraouf, Diken, Mustafa, Koslowski, Michael, Britten, Cedrik M., Huber, Christoph, Türeci, Özlem, Sahin, Ugur·2010·Cancer Research

DOI 10.1158/0008-5472.can-10-0699

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Although naked antigen-encoding RNA has entered clinical testing, basic knowledge on how to apply this promising novel vaccine format is still pending. By comparing different administration routes, we observed surprisingly potent antigen-specific T-cell immunity upon intranodal injection of naked antigen-encoding RNA. RNA was selectively uptaken by resident dendritic cells, propagated a T-cell attracting and stimulatory intralymphatic milieu, and led to efficient expansion of antigen-specific CD8+ as well as CD4+ T cells. By intranodal treatment of mice with repeated cycles of RNA, we achieved de novo priming of naïve T cells, which became potent cytolytic effectors capable of homing to primary and secondary lymphatic tissues as well as memory T cells. In tumor-bearing mice intralymphatic RNA vaccination elicited protective and therapeutic antitumor immune responses, resulting in a remarkable survival benefit as compared with other treatment regimens. This is the first report of strong systemic antigen-specific Th1-type immunity and cancer cure achieved with naked antigen-encoding RNA in preclinical animal models. Cancer Res; 70(22); 9031–40. ©2010 AACR.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-0699

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Immunobiology of Dendritic Cells
Banchereau, J., Brière, F., Caux, C., Davoust, J. M., Lebecque, S., Liu, Y., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,755
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.465 · Cited by 915
B70 antigen is a second ligand for CTLA-4 and CD28
Azuma, M., Ito, D., Yagita∥, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993) · Nature · doi:10.1038/366076a0 · Cited by 910
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction
Castellino, F., Huang, A. Y.-C., Altan-Bonnet, G. Y., Stoll, S., Scheinecker, C., & Germain, R. N. (2006) · Nature · doi:10.1038/nature04651 · Cited by 847
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625
Self-citation
Inflammatory Cytokines Provide a Third Signal for Activation of Naive CD4+ and CD8+ T Cells
Curtsinger, J., Schmidt, C. S., Mondino, A., Lins, D. C., Kedl, R. M., Jenkins, M. K., & Mescher, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3256 · Cited by 610
Cutting Edge: Generation of Splenic CD8+ and CD8− Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures
Naik, S. H., Proietto, A. I., Wilson, N. S., Dakic, A., Schnorrer, P., Fuchsberger, M., Lahoud, M. H., O’Keeffe, M. A., Shao, Q.-X., Chen, W. F., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6592 · Cited by 551

Show all 34 references

Sorted by citations

Items 201–300 of 309

Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects
Li, M., Xie, Y., Zhang, J., Zhou, X., Gao, L., He, M., Liu, X., Miao, X., Liu, Y., Cao, R., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217111 · Cited by 16
FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines
Kreiter, S., Diken, M., Selmi, A., Petschenka, J., Türeci, Ö., & Şahin, U. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3625-0_11 · Cited by 16
Self-citation
Advances in mRNA vaccine therapy for breast cancer research
Li, J., Jiang, R., Wang, J., & Wang, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02542-y · Cited by 16
Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis
Morisaki, T., Morisaki, T., Kubo, M., Onishi, H., Hirano, T., Morisaki, S., Eto, M., Monji, K., Takeuchi, A., NAKAGAWA, S., et al. (2021) · Anticancer Research · doi:10.21873/anticanres.15213 · Cited by 15
Revolutionizing cancer treatment: the rise of personalized immunotherapies
Fayyaz, A., Haqqi, A., Khan, R., Irfan, M., Khan, K., Reiner, Ž., Sharifi‐Rad, J., & Călina, D. C. (2024) · Discover Oncology · doi:10.1007/s12672-024-01638-1 · Cited by 18
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
Sayour, E. J., Sanchez-Perez, L. A., Flores, C., & Mitchell, D. A. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0058-0 · Cited by 15
Nanoengineered Strategies to Optimize Dendritic Cells for Gastrointestinal Tumor Immunotherapy: From Biology to Translational Medicine
Bhargava, A., Bunkar, N., Khare, N. K., Mishra, D. K., & Mishra, P. K. (2014) · Nanomedicine · doi:10.2217/nnm.14.115 · Cited by 15
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
Belay, W. Y., Nibret, G., & Aschale, Y. (2023) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s418314 · Cited by 16
Intradermal Delivery of Naked mRNA Vaccines via Iontophoresis
Hasan, M., Khatun, A., & Kogure, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122678 · Cited by 14
Rational design of polymer-based mRNA delivery systems for cancer treatment
Wan, Q., Sun, Y., Sun, X., & Zhou, Z. (2024) · Polymer Chemistry · doi:10.1039/d4py00206g · Cited by 15
Advances and Strategies in Enhancing mRNA Cancer Vaccines
Zhang, M., Chen, S., Hu, H.-J., Ong, Y., & Ni, Q. (2025) · Advanced Materials · doi:10.1002/adma.202509880 · Cited by 17
Brief Insights into mRNA Vaccines: Their Successful Production and Nanoformulation for Effective Response against COVID-19 and Their Potential Success for Influenza A and B
Parveen, A., & Elkordy, A. (2024) · Pathogens · doi:10.3390/pathogens13060500 · Cited by 13
Advancing tumor vaccines: Overcoming TME challenges, delivery strategies, and biomaterial-based vaccine for enhanced immunotherapy
Zeng, Q., Zhang, S., Leng, N., & Xing, Y. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104576 · Cited by 13
Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines
Twilhaar, M. K. N., Czentner, L., van Nostrum, C. F., Storm, G., & den Haan, J. M. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070954 · Cited by 13
Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)
Volovăț, S. R., Negru, S. M., Stolniceanu, C. R., Volovat, C. D., Lungulescu, C. V., Scripcariu, D. V., Cobzeanu, B. M., Ştefănescu, C., Grigorescu, C., Augustin, I. G., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9967 · Cited by 14
Ribonuclease activity undermines immune sensing of naked extracellular RNA
Castellano, M., Blanco, V., Calzi, M. L., Costa, B., Witwer, K. W., Hill, M., Cayota, A., Segovia, M., & Tosar, J. P. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100874 · Cited by 13
Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences
Rhoads, R. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3625-0_1 · Cited by 11
Smuggling on the Nanoscale—Fusogenic Liposomes Enable Efficient RNA-Transfer with Negligible Immune Response In Vitro and In Vivo
Hoffmann, M., Gerlach, S., Takamiya, M., Tarazi, S., Hersch, N., Csiszár, Á., Springer, R., Dreissen, G., Scharr, H., Rastegar, S., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041210 · Cited by 11
An Insight into Immunological Therapeutic Approach against Cancer: Potential Anti-cancer Vaccines
Kohli, A. S., Sanyal, S., Kaushal, R. S., & Dwivedi, M. (2024) · Current Genomics · doi:10.2174/0113892029319505240821063238 · Cited by 11
Individualized Neoantigen-Directed Melanoma Therapy
Khaddour, K., & Buchbinder, E. I. (2025) · American Journal of Clinical Dermatology · doi:10.1007/s40257-025-00920-4 · Cited by 13
Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia
Mishra, R., Sukhbaatar, A., Mori, S., & Kodama, T. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02645-w · Cited by 11
RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement
Abdelzaher, H. M., Gabr, A. S., Saleh, B. M., Gawad, R. M. A., Nour, A. A., & Abdelnaser, A. (2021) · Vaccines · doi:10.3390/vaccines9111211 · Cited by 12
The mRNA-Based Innovative Strategy: Progress and Challenges
Zhou, H., Wei, D., Chen, Z., Chen, H., Dong, C., Cai, W., Wang, J., Liu, X., Li, Y., Yang, Y., et al. (2026) · Nano-Micro Letters · doi:10.1007/s40820-025-01906-x · Cited by 17
Polyamine‐Mediated Stoichiometric Assembly of Ribonucleoproteins for Enhanced mRNA Delivery
Li, J., He, Y., Wang, W., Wu, C., Hong, C., & Hammond, P. T. (2017) · Angewandte Chemie · doi:10.1002/ange.201707466 · Cited by 10
A Brief Introduction to Current Cancer Gene Therapy
Kobelt, D., Pahle, J., & Walther, W. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2441-8_1 · Cited by 12
Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics
Ye, L., Zhao, G., Ma, J., Gan, Q., Luo, N., Pan, D., Chen, C., Chen, X., & Ning, S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02769-3 · Cited by 10
Emerging trends of research on mRNA vaccines: A co-citation analysis
Chen, J., Zhang, T., Lu, Y. Z., Yang, X., & Ouyang, Z. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2110409 · Cited by 10
The mRNA Vaccine Heralds a New Era in Vaccinology
Shinde, K., Bendre, S., Kale, N., & Gilda, S. (2022) · Asian Journal of Pharmacy and Technology · doi:10.52711/2231-5713.2022.00042 · Cited by 9
Measuring the Adjuvant Activity of RNA Vaccines
Pardi, N., & Weissman, D. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_8 · Cited by 9
Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma Models
Salomon, N., Helm, A., Selmi, A., Fournier, C., Diken, M., Schrörs, B., Scholz, M., Kreiter, S., Durante, M., & Vascotto, F. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.12.042 · Cited by 7
Self-citation
A Review of Clinical Trials of Cancer and Its Treatment as a Vaccine
Chandarana, C. V., & Tiwari, A. (2023) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871260733231031081921 · Cited by 7
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective
Accordino, G., Lettieri, S., Bortolotto, C., Benvenuti, S., Gallotti, A., Gattoni, E., Agustoni, F., Pozzi, E., Rinaldi, P., Primiceri, C., et al. (2020) · Cancers · doi:10.3390/cancers12082105 · Cited by 7
Messenger RNA Vaccines
Probst, J., Fotin‐Mleczek, M., Schlake, T., Theß, A., Kramps, T., & Kallen, K. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0439-2_11 · Cited by 7
Next-Generation Therapeutics: mRNA as a Novel Therapeutic Option for Single-Gene Disorders
Michel, T., Wendel, H.-P., & Krajewski, S. (2016) · InTech eBooks · doi:10.5772/62243 · Cited by 7
Parenteral Vaccine Administration: Tried and True
Johansen, P., & Kündig, T. M. (2014) · Advances in delivery science and technology · doi:10.1007/978-1-4939-1417-3_14 · Cited by 7
Jet injection potentiates naked mRNA SARS-CoV-2 vaccine in mice and non-human primates by adding physical stress to the skinPreprint
Abbasi, S., Matsui-Masai, M., Yasui, F., Hayashi, A., Tockary, T. A., Akinaga, S., Kohara, M., Kataoka, K., & Uchida, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.27.530188 · Cited by 8
mRNA aggregates harness danger response for potent cancer immunotherapyPreprint
Méndez‐Gómez, H. R., DeVries, A., Castillo, P., Stover, B. D., Qdaisat, S., Roemeling, C. A. V., Ogando‐Rivas, E., Weidert, F. L., McGuiness, J., Zhang, D., et al. (2023) · medRxiv · doi:10.1101/2023.03.12.23287108 · Cited by 7
Emerging Therapeutic Strategies for Lung Cancer: The Role of Immunotherapy and HPV-Targeted Cancer Vaccines
Bhaliya, K., Anwer, M., & Wei, M. Q. (2025) · Vaccines · doi:10.3390/vaccines13090957 · Cited by 7
Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant Approach
Josi, R., Ogrina, A., Rothen, D. A., Baļķe, I., Solé, A., de Brot, S., & Mohsen, M. O. (2024) · Vaccines · doi:10.3390/vaccines12040355 · Cited by 6
Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history
Pascolo, S. (2023) · European Journal of Immunology · doi:10.1002/eji.202249941 · Cited by 6
mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond
Prakash, S. (2023) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-023-00849-1 · Cited by 6
Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format
Diken, M., Kreiter, S., Kloke, B., & Şahin, U. (2015) · Progress in tumor research · doi:10.1159/000437184 · Cited by 6
Self-citation
Lymph node targeting for improved potency of cancer vaccine
Du, G., & Sun, X. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00019-3 · Cited by 6
Pipe dream to pipeline: Journey of cancer vaccines and the road ahead
Onkar, S., Bozkus, C. C., Saxena, M., & Bhardwaj, N. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102575 · Cited by 5
Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy
Adhikary, K., Paul, A., Madan, A., Islam, A., Ashique, S., & Ramzan, M. (2025) · Advances in immunology · doi:10.1016/bs.ai.2024.10.011 · Cited by 6
Priming of cytotoxic T lymphocyte responses by dendritic cells: induction of potent anti-tumor immune responses
Lint, S. V., Nuffel, A. M. T. V., Wilgenhof, S., Benteyn, D., Pen, J. J., Escors, D., Bonehill, A., Neyns, B., Thielemans, K., & Breckpot, K. (2013) · Ghent University Academic Bibliography (Ghent University) · Cited by 5
RNA in cancer vaccine therapy
Nair, S. K., Boczkowski, D., Pruitt, S. K., & Urban, J. H. (2011) · Informa Healthcare eBooks · doi:10.3109/9781841848303.016 · Cited by 5
A extrafiscalidade e os controles de proporcionalidade e de igualdade
Papadopol, M. D. (2009) · Americanae (AECID Library) · Cited by 5
Neo‐Antigen‐Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach
Chen, G., Kong, D., & Lin, Y. (2023) · Global Challenges · doi:10.1002/gch2.202200186 · Cited by 3
Introduction to RNA Vaccines Post COVID-19
Kramps, T. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3770-8_1 · Cited by 4
Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy
Devi, G. R., & Nath, S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3625-0_15 · Cited by 4
Nanotechnology and Immunomodulators in Cancer
Volovat, C. D., Volovăț, S. R., & Agop, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-6379-6_5 · Cited by 4
Technological advances in mRNA delivery and engineering for therapeutic cancer vaccines
Uchida, S. (2025) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaf199 · Cited by 4
Innovative combinatory approaches with dendritic cell-based vaccines: bridging preclinical insights and clinical challenges
Khanmiri, J. M., Khani-Eshratabadi, M., Seyedmoharrami, F., Khazaee‐Nasirabadi, M. H., Dehdashti, M., Seddighi, N., Peymaninezhad, F., Khiabani, A., Khanahmad, A., & Baradaran, B. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02056-z · Cited by 5
Molecular tautomerism-induced formation of supramolecular hydrogel for mRNA enrichment and delivery
Lyu, Y., Peng, M., Hu, Y., Hu, X., Zhang, Y., Zhao, P., Wang, T., Xu, S., Zhang, K., & Bian, L. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100124 · Cited by 4
RNA Vaccines: The Evolution, Applications, and the Challenges Ahead
Banerji, I., Bhattacharjee, S., Mukherjee, K., & Bhattacharyya, S. N. (2023) · Springer eBooks · doi:10.1007/978-981-19-8520-1_10 · Cited by 3
Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses
Albadr, R. J., Sameer, H. N., Athab, Z. H., Adil, M., Yaseen, A., & Allela, O. Q. B. (2025) · Biological Procedures Online · doi:10.1186/s12575-025-00269-2 · Cited by 4
mRNA Vaccination and Personalized Cancer Therapy
Kreiter, S., Diken, M., & Şahin, U. (2014) · Springer eBooks · doi:10.1007/978-3-319-05104-8_9 · Cited by 3
Self-citation
Targeting Melanoma Sites in Vivo can Induce Complete Tumor Ablation and Prolong Patient Survival: An Exploratory Study
Elias, E. G. (2013) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000212 · Cited by 3
The Characteristics of RNA Vaccine; its Strengths and Weaknesses
Park, H., Ko, H. L., Jung, S.-Y., Jo, H.-B., & Nam, J. (2016) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2016.46.3.115 · Cited by 3
Administration routes for the delivery of vaccines and immunotherapeutics
Johansen, P., & Kündig, T. M. (2013) · doi:10.4155/ebo.12.430 · Cited by 3
A Historical Overview on mRNA Vaccine Development
Verbeke, R., Cheng, M. H. Y., & Cullis, P. R. (2024) · Wiley eBooks · doi:10.1002/9783527838394.ch1 · Cited by 5
Recent advances in LNP-mRNA vaccines
Redenti, B. J., Zhong, Y., Yu, C., & Dong, Y. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115675 · Cited by 3
Genetic Vaccine for Cancer
Valilou, S. F., & Keshavarz‐Fathi, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814039-0.00010-2 · Cited by 2
Personalized neoantigen-based cancer immunotherapy. A literature review
Aguirre, J. P. O., Vargas, E. A. V., Bohórquez, O. M. R., Amaya-Ramírez, D., Bernal-Estévez, D. A., & Parra-López, C. (2021) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v69n3.81633 · Cited by 2
Local immunotherapy of cancer and metastasis
Kwon, S., & Yeo, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00018-x · Cited by 2
Intra‐lymph node crosslinking of antigen‐bearing polymers enhances humoral immunity and dendritic cell activation
Euliano, E. M., Agrawal, A., Yu, M. H., Graf, T. P., Henrich, E. M., Kunkel, A. A., Hsu, C., Baryakova, T. H., & McHugh, K. J. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10705 · Cited by 2
Transcriptomic characterization of human pancreatic CD206- and CD206 + macrophages
Jönsson, A., Korsgren, O., & Hedin, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-96313-y · Cited by 3
mRNA-based vaccines and therapies - a revolutionary approach for conquering fast-spreading infections and other clinical applications: a review
Pan, M., Cao, W., Zhai, J., Zheng, C., Xu, Y., & Zhang, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143134 · Cited by 2
The impact of intraoperative vaccination with IL-12 modified autologous tumor cells in the Lewis lung carcinoma mouse model
Dietrich, A., Stockmar, C., Endesfelder, S., Guetz, A., & Aust, G. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1160-z · Cited by 2
Bottlenecks and opportunities in immunotherapy for glioma: a narrative review
Shi, Y. K., Wu, M., Liu, Y., Chen, L., Bian, X., & Xu, C. S. (2022) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000135 · Cited by 2
Learning from cancer to address COVID-19
Oláh, E. (2023) · Biologia Futura · doi:10.1007/s42977-023-00156-5 · Cited by 2
Programmable Aptamer-Embedded Circular RNAs for Targeted Antigen-Presenting Cells ImmunotherapyPreprint
Zhang, Y., Wang, W., Qian, X., Chen, J., Ding, D., Gan, S., Yi, W., Li, Y., Deng, Y., Chen, Z., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.28.679023 · Cited by 3
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
Billmeier, A., Khinvasara, K., Lang, F., Mohr, J., Reidenbach, D., Schork, M., Yildiz, I., & Diken, M. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2024416 · Cited by 1
Self-citation
Sequence-Optimized mRNA Vaccines Against Infectious Disease
Rauch, S., Lutz, J., Mühe, J., Kowalczyk, A., Schlake, T., & Heidenreich, R. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3770-8_8 · Cited by 2
The mRNA vaccine contributors: Assessing their impact through a mainstream lens
Ho, M. H., Liu, J. S., Wang, W., & Chuang, T. C. (2025) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2025.124200 · Cited by 1
CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy
Kranz, L. M., Birtel, M., Krienke, C., Grunwitz, C. R., Petschenka, J., Reuter, K. C., van de Roemer, N., Vascotto, F., Vormehr, M., Kreiter, S., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1068485 · Cited by 1
Self-citation
Cancer vaccines: translational strategies
Maeng, H. M., & Berzofsky, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820493-1.00033-7 · Cited by 1
Le rôle des ganglions lymphatiques drainant la tumeur à l’ère des immunothérapies
Tosello, J., Borcoman, É., Sedlik, C., & Piaggio, E. (2022) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.11.025 · Cited by 1
Intralymphatic Vaccination
Kündig, T. M., Bot, A. I., & Senti, G. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0439-2_10 · Cited by 1
Entwicklung von RNA‐basierten Impfstoffen
Roos, T. (2015) · Biologie in unserer Zeit · doi:10.1002/biuz.201510555 · Cited by 1
pDNA and mRNA vaccines
Gill, K., Minall, L., & Nassif, A. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814357-5.00007-6 · Cited by 1
CIMT 2014: Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy
Diken, M., Boegel, S., Grunwitz, C. R., Kranz, L. M., Reuter, K. C., van de Roemer, N., Vascotto, F., Vormehr, M., & Kreiter, S. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29767
Self-citation
Biotechnologie 2.0 — Impfstoffe und Medikamente auf Basis von mRNA
Theß, A., & Grund, S. E. (2014) · BIOspektrum · doi:10.1007/s12268-014-0483-5
Studies on therapeutic vaccination and immune evasion in chronic lymphocytic leukemia
Junevik, K. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Augmenting the Skin Immune System
Nasir, A., & Gaspari, A. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5034-4_15
Immunogenicity of a mRNA-based vaccine encoding the House Dust Mite allergen Derp1
van Weijnen, A. (2014)
RNA vaccines for anti-tumor therapy
Benencia, F. (2013) · World Journal of Experimental Medicine · doi:10.5493/wjem.v3.i4.62
The Development of Tumor Neoantigen Vaccine Immunotherapy
Wang, W. (2019) · E3S Web of Conferences · doi:10.1051/e3sconf/20197801005
Expressão da proteína de capsídeo recombinante do vírus Semliki Forest e sua associação in vitro com RNA auto replicativo
Gomes, R. P. (2019) · doi:10.11606/d.87.2019.tde-10042019-103505
Immunotherapy with mRNA vaccination and immunomodulation nanomedicine for cancer therapy
Madkour, L. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819777-6.00021-4
Historical Development Process of mRNA Vaccines and SARS-CoV-2 Pandemic
GÜNEŞ, N., & Karabulut, Ş. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2020.14
Platform Technologies for Improving in vivo Functionalities of mRNA Therapeutics
Uchida, S. (2021) · Journal of the Society of Powder Technology Japan · doi:10.4164/sptj.58.627
Faculty Opinions recommendation of Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose.
Tomalia, D. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726487211.793560191
Data from mTOR Inhibition Improves Antitumor Effects of Vaccination with Antigen-Encoding RNA
Diken, M., Kreiter, S., Vascotto, F., Selmi, A., Attig, S., Diekmann, J., Huber, C., Türeci, Ö., & Şahin, U. (2023) · doi:10.1158/2326-6066.c.6548213.v1
Self-citation
mRNA Vaccine for Infectious Disease Prevention and Cancer Immunotherapy
Dong, J. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/3/20220236
mRNA vaccine encoding neoantigen for cancer immunotherapy using mouse melanoma as a model
Sittplangkoon, C., & Palaga, T. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.23
Solutions for mRNA Optimization
Lemonnier, J., & Lemonnier, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-39300-6_9
Cancer Vaccines Based on mRNA: Hype or Hope?
de Mey, W., Autaers, D., Bertazzon, G., Esprit, A., Aragon, M. M., Franceschini, L., & Breckpot, K. (2024) · Wiley eBooks · doi:10.1002/9783527838394.ch13
Novel approaches to immuno-oncology
Chen, R., & Su, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00047-3

Authors: Kreiter, S., Selmi, A., Diken, M., Koslowski, M., Britten, C. M., Huber, C., Türeci, Ö., & Sahin, U.
Affiliations: Johannes Gutenberg University Mainz (DE)
Authors' Affiliations: 1Center for Translational Oncology and Immunology (TRON), 2Ribological, Biontech AG, and 3Department of Internal Medicine III, Division of Translational and Experimental Oncology, Johannes Gutenberg University, Mainz, Germany
ORCID: Kreiter, Sebastian
Diken, Mustafa
Koslowski, Michael
Britten, Cedrik M.
Türeci, Özlem
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2010-11-14
Volume: 70
Issue: 22
Pages: 9031-9040
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-10-0699
OpenAlex: W2125677437
Cited by: 309
References: 34
Citations by year: 2026: 10 · 2025: 16 · 2024: 25 · 2023: 30 · 2022: 21 · 2021: 22 · 2020: 23 · 2019: 13 · 2018: 17 · 2017: 20 · 2016: 19 · 2015: 23 · 2014: 21 · 2013: 22 · 2012: 13
FWCI: 6.59
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Funders: Bundesministerium für Bildung und Forschung
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: intranodal injection, dendritic cells, CD8+ T cells, CD4+ T cells, Th1 response, antitumor immunity, prophylactic and therapeutic vaccination, T cell homing, memory T cells, cancer immunotherapy
MeSH terms: Animals, Antigens, Cytotoxicity, Immunologic, Dendritic Cells, Flow Cytometry, Immunization, Lymph Nodes, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Neoplasms, Experimental, RNA, CD4-Positive T-Lymphocytes, Survival Analysis, Mice, Knockout, CD8-Positive T-Lymphocytes, Cancer Vaccines, Cell Line, Tumor, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks